Skip to search formSkip to main contentSkip to account menu

1.5 ML Somatropin 6.67 MG/ML Cartridge [Omnitrope]

Known as: Omnitrope 10 MG in 1.5 ML Cartridge, SOMATROPIN (OMNITROPE) 10MG/1.5ML INJ,SOLN,CARTRIDGE, SOMATROPIN 10 mg in 1.5 mL SUBCUTANEOUS INJECTION, SOLUTION [Omnitrope] 
National Institutes of Health

Related topics

Related topics

19 relations
Brain NeoplasmsCachexiaCartridgeCongestive heart failure

Broader (1)

Pituitary Hormones, Anterior

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Ten years of biosimilar recombinant human growth hormone in Europe
  • P. Saenger
  • Drug Design, Development and Therapy
  • 2017
  • Corpus ID: 6818718
Recombinant human growth hormone (rhGH) has been in clinical use for more than 30 years. With the expiration of patent… 
2017
2017
Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study
PurposeTo report the long-term effectiveness and safety of the recombinant human growth hormone Omnitrope®, a somatropin… 
2017
2017
Traitement par Omnitrope® de patients adultes présentant un déficit somatotrope sévère : résultats intermédiaire de l’étude PATRO Adults en France
2014
2014
Two-Year Data from a Long-Term, Phase IV Study of Omnitrope ® , a Recombinant Human GH, in Short Children Born Small for Gestational Age
2013
2013
Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis
Background Treatment of growth hormone disorders typically involves daily injections of human growth hormone (GH) over many years… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)